FDA panel advises against large opioid-constipation drug trials
June 12, 2014 at 12:34 PM EDT
June 12 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended on Thursday that the agency not require large cardiovascular safety trials for a class of drugs used to treat opioid-induced chronic constipation.